TL;DR
Get health and wellness essentials delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
MedPage Today’s Oct. 11, 2026, roundup collected eight comments from clinicians and health leaders on recent health news and research. Topics included FDA warnings about unapproved herpes products sold on Amazon, the federal response to measles, hospital infection prevention, vaping exposure and early-stage treatment research.
MedPage Today published an eight-quote roundup on October 11, collecting reactions from physicians and health leaders to recent developments in medicine and public health. The comments addressed unapproved herpes treatments sold on Amazon, the federal response to a U.S. measles outbreak, and several studies on patient safety and emerging therapies.
The headline quote came from Jeffrey Klausner, a physician with Herpes Cure Advocacy, responding to news that the Food and Drug Administration had warned Amazon over sales of unapproved herpes treatments. “The public should not be subject to these quack medicines,” he said. The roundup reports the warning and Klausner’s response; it does not provide the FDA letter’s details or Amazon’s response.
Other comments focused on public health and health policy. Jeanne Marrazzo, former director of the National Institute of Allergy and Infectious Diseases, called the federal government’s response to the U.S. measles outbreak “extremely underwhelming and frankly shameful.” The article also quoted Jennifer Mensik Kennedy, president of the American Nurses Association, on 18 nurses running for Congress in the election: “Look at the number of lawyers in office. We should have more nurses.”
The roundup included remarks on hospital efforts to prevent catheter-associated urinary tract infections, children with asthma exposed to vaping and tobacco smoke, and a reported spike in a rare fungal infection. It also cited early research into radiosurgical capsulotomy for treatment-resistant depression and suicidal ideation, and optogenetic therapy for advanced retinitis pigmentosa. The source presents these as comments on studies and developments, not as evidence that experimental approaches are established treatments.
Public Health Concerns and Research
The range of topics shows how the roundup links immediate safety concerns with questions raised by new research. Unapproved products and measles response involve public health oversight and confidence in official action. Comments on vaping exposure and infection prevention point to risks that clinicians encounter in everyday care.
The treatment-related remarks require a different level of caution. A result described as dramatic in a small study does not establish that an intervention is safe or effective for wider use. Mohamed Khattab called radiosurgical capsulotomy “potentially” life-saving, while Richard Rosen said clinicians have few options for some people with advanced retinitis pigmentosa. Those statements convey unmet needs and possible research directions; they do not confirm clinical benefit.
As an affiliate, we earn on qualifying purchases.
Eight Topics Behind the Quotes
MedPage Today’s “What We Heard This Week” format gathers short quotations from its reporters’ coverage rather than presenting one unified investigation. The October 11 edition covers eight separate subjects, from an FDA warning about products marketed for herpes to studies involving infection control, environmental exposure and experimental therapies.
The source gives brief descriptions, not full reports on each underlying event or study. For example, it says U.S. hospitals are increasingly embracing strategies to prevent catheter-associated urinary tract infections, and that a study examined children with asthma exposed to vaping and combustible tobacco. It does not supply study sizes, methods, dates or numerical findings in this roundup.
““The public should not be subject to these quack medicines.””
— Jeffrey Klausner, MD, MPH, of Herpes Cure Advocacy
hospital infection prevention supplies
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Details Not Included in the Roundup
The source does not provide the FDA’s specific concerns about the products, the warning’s terms, or Amazon’s response. It also gives no detailed account of the federal actions Marrazzo criticized or the status and scale of the measles outbreak.
For the research topics, the roundup does not include study designs, participant numbers beyond describing one study as small, effect sizes or follow-up periods. The reported fungal infection spike is not quantified, and its cause is not described. The comments should not be read as independent confirmation of the underlying findings or as evidence that experimental treatments are ready for routine care.
As an affiliate, we earn on qualifying purchases.
Follow-Up on Warnings and Studies
Further reporting would be needed to establish how Amazon responds to the FDA warning and whether the agency identifies particular products or enforcement steps. Updates on the measles outbreak and the government response would clarify the scope of the criticism Marrazzo raised.
Readers seeking fuller evidence on the research topics will need the original studies and subsequent reporting, including details on methods, results and limitations. The roundup itself announces no upcoming decision, publication date or regulatory milestone; next steps for the studies and policy issues remain unspecified in the source.
experimental depression treatment devices
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Key Questions
What did MedPage Today publish?
It published an October 11, 2026, roundup of eight quotations from health professionals and leaders reacting to recent medical news and research.
What prompted the headline quote about herpes treatments?
Jeffrey Klausner was responding to news that the FDA had warned Amazon for selling unapproved herpes treatments. The roundup does not include the warning’s full details or Amazon’s response.
What did the roundup say about measles?
Former infectious-disease institute director Jeanne Marrazzo criticized the federal government’s response to a U.S. measles outbreak. The source does not describe the outbreak’s size or the specific actions she was referring to.
Do the quotes establish that the experimental treatments work?
No. The roundup briefly describes research on radiosurgical capsulotomy and optogenetic therapy but does not provide enough study information to establish safety or effectiveness. One study is explicitly described as small.
Source: rss
Fall Picks
fall essentials
As an affiliate, we earn on qualifying purchases.
